These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8505149)

  • 61. Lateral diffusion of CD4 on the surface of a human neoplastic T-cell line probed with a fluorescent derivative of the envelope glycoprotein (gp120) of human immunodeficiency virus type 1 (HIV-1).
    Pal R; Nair BC; Hoke GM; Sarngadharan MG; Edidin M
    J Cell Physiol; 1991 May; 147(2):326-32. PubMed ID: 2040664
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Construction of a binding site for human immunodeficiency virus type 1 gp120 in rat CD4.
    Schockmel GA; Somoza C; Davis SJ; Williams AF; Healey D
    J Exp Med; 1992 Jan; 175(1):301-4. PubMed ID: 1730924
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Internalization and recycling of CD4 transfected into HeLa and NIH3T3 cells.
    Pelchen-Matthews A; Armes JE; Marsh M
    EMBO J; 1989 Dec; 8(12):3641-9. PubMed ID: 2583114
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Detection of receptor-ligand interactions using surface plasmon resonance: model studies employing the HIV-1 gp120/CD4 interaction.
    Brigham-Burke M; Edwards JR; O'Shannessy DJ
    Anal Biochem; 1992 Aug; 205(1):125-31. PubMed ID: 1443549
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Syncytium formation and destruction of bystander CD4+ cells cocultured with T cells persistently infected with human immunodeficiency virus as demonstrated by flow cytometry.
    Schols D; Pauwels R; Baba M; Desmyter J; De Clercq E
    J Gen Virol; 1989 Sep; 70 ( Pt 9)():2397-408. PubMed ID: 2789268
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Analysis of human CD4-antibody interaction using the BIAcore system.
    Velge-Roussel F; Breton P; Lescure F; Guillon X; Bout D; Hoebeke J
    J Immunol Methods; 1995 Jun; 183(1):141-8. PubMed ID: 7602132
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Dissociation of gp120 from HIV-1 virions induced by soluble CD4.
    Moore JP; McKeating JA; Weiss RA; Sattentau QJ
    Science; 1990 Nov; 250(4984):1139-42. PubMed ID: 2251501
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Modulation of CD4 lateral mobility in intact cells by an intracellularly applied antibody.
    Grebenkämper K; Tosi PF; Lazarte JE; Sneed L; Brüggemann U; Kubitscheck U; Nicolau C; Peters R
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):251-9. PubMed ID: 7492321
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of optimal anion spacing for anti-HIV activity in a series of cosalane tetracarboxylates.
    Paul GC; De Clercq E; Pannecouque C; Witvrouw M; Loftus TL; Turpin JA; Buckheit RW; Cushman M
    Bioorg Med Chem Lett; 2000 Sep; 10(18):2149-52. PubMed ID: 10999491
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evaluation of monoclonal antibodies to HIV-1 envelope by neutralization and binding assays: an international collaboration.
    D'Souza MP; Geyer SJ; Hanson CV; Hendry RM; Milman G
    AIDS; 1994 Feb; 8(2):169-81. PubMed ID: 7519019
    [TBL] [Abstract][Full Text] [Related]  

  • 71. T-cell membrane-associated serine protease, tryptase TL2, binds human immunodeficiency virus type 1 gp120 and cleaves the third-variable-domain loop of gp120. Neutralizing antibodies of human immunodeficiency virus type 1 inhibit cleavage of gp120.
    Niwa Y; Yano M; Futaki S; Okumura Y; Kido H
    Eur J Biochem; 1996 Apr; 237(1):64-70. PubMed ID: 8620895
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Increased, Durable B-Cell and ADCC Responses Associated with T-Helper Cell Responses to HIV-1 Envelope in Macaques Vaccinated with gp140 Occluded at the CD4 Receptor Binding Site.
    Bogers WMJM; Barnett SW; Oostermeijer H; Nieuwenhuis IG; Beenhakker N; Mortier D; Mooij P; Koopman G; Remarque E; Martin G; Lai RP; Dey AK; Sun Y; Burke B; Ferrari G; Montefiori D; Martin L; Davis D; Srivastava I; Heeney JL
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701402
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Characterization of antibodies that inhibit HIV gp120 antigen processing and presentation.
    Tuen M; Visciano ML; Chien PC; Cohen S; Chen PD; Robinson J; He Y; Pinter A; Gorny MK; Hioe CE
    Eur J Immunol; 2005 Sep; 35(9):2541-51. PubMed ID: 16106369
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Potent anti-HIV (type 1 and type 2) activity of polyoxometalates: structure-activity relationship and mechanism of action.
    Witvrouw M; Weigold H; Pannecouque C; Schols D; De Clercq E; Holan G
    J Med Chem; 2000 Mar; 43(5):778-83. PubMed ID: 10715146
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Novel CD4-Based Bispecific Chimeric Antigen Receptor Designed for Enhanced Anti-HIV Potency and Absence of HIV Entry Receptor Activity.
    Liu L; Patel B; Ghanem MH; Bundoc V; Zheng Z; Morgan RA; Rosenberg SA; Dey B; Berger EA
    J Virol; 2015 Jul; 89(13):6685-94. PubMed ID: 25878112
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Enzyme immunoassay (ELISA) for the evaluation of antibodies directed to the CD4 receptor-binding site of the HIV gp120 molecule.
    Hinkula J; Gidlund M; Persson C; Osterhaus A; Wahren B
    J Immunol Methods; 1994 Sep; 175(1):37-46. PubMed ID: 7523525
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Antibody raised against soluble CD4-rgp120 complex recognizes the CD4 moiety and blocks membrane fusion without inhibiting CD4-gp120 binding.
    Celada F; Cambiaggi C; Maccari J; Burastero S; Gregory T; Patzer E; Porter J; McDanal C; Matthews T
    J Exp Med; 1990 Oct; 172(4):1143-50. PubMed ID: 2212945
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Species specificity and augmentation of responses to class II major histocompatibility complex molecules in human CD4 transgenic mice.
    Barzaga-Gilbert E; Grass D; Lawrance SK; Peterson PA; Lacy E; Engelhard VH
    J Exp Med; 1992 Jun; 175(6):1707-15. PubMed ID: 1534116
    [TBL] [Abstract][Full Text] [Related]  

  • 79. CD4-binding compounds: an assay to detect new classes of immunopharmacological agents.
    Chandler G; Elcock C; Depledge P; Wrigley S; Mous J; Malkovsky M; Moore M; Gammon G
    Int J Immunopharmacol; 1993 Apr; 15(3):361-9. PubMed ID: 8505149
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A fungal metabolite which inhibits the interaction of CD4 with major histocompatibility complex-encoded class II molecules.
    Gammon G; Chandler G; Depledge P; Elcock C; Wrigley S; Moore J; Cammarota G; Sinigaglia F; Moore M
    Eur J Immunol; 1994 Apr; 24(4):991-8. PubMed ID: 8149967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.